Package 55513-670-21

{"route": ["INTRAVENOUS"], "spl_id": "6b1480b9-1db9-4bbc-91e3-e967574f2055", "openfda": {"nui": ["N0000175610", "N0000175451"], "unii": ["B72HH48FLU"], "rxcui": ["2266525", "2266530"], "spl_set_id": ["de34bcb7-b524-45c8-9181-61c6f48d540e"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "manufacturer_name": ["Amgen, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55513-670-01)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55513-670-01", "marketing_start_date": "20191212"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55513-670-21)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55513-670-21", "marketing_start_date": "20250901"}], "brand_name": "AVSOLA", "product_id": "55513-670_6b1480b9-1db9-4bbc-91e3-e967574f2055", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Tumor Necrosis Factor Blocker [EPC]", "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "product_ndc": "55513-670", "generic_name": "infliximab-axxq", "labeler_name": "Amgen, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AVSOLA", "active_ingredients": [{"name": "INFLIXIMAB", "strength": "100 mg/10mL"}], "application_number": "BLA761086", "marketing_category": "BLA", "marketing_start_date": "20191212", "listing_expiration_date": "20261231"}